General principles for systematic reviews and meta-analyses and a critique of a recent systematic review of long-acting β-agonists

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 2, 2007, Pages 303-306

  Chinchilli, Vernon M ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

fixed effects models; funnel plots; literature search; Overviews; publication bias; random effects models

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE PROPIONATE; LONG ACTING DRUG; PLACEBO; SALMETEROL;

ASTHMA; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; FATALITY; HUMAN; META ANALYSIS; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTEMATIC ERROR; SYSTEMATIC REVIEW;

ADRENERGIC BETA-AGONISTS; ASTHMA; HUMANS; META-ANALYSIS; REVIEW LITERATURE;

EID: 33846827189     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.11.632     Document Type: Review

References (16)

1. Cook D.J., Sackett D.L., and Spitzer W.O. Methodologic guidelines for systematic reviews of randomized controlled trials in health care from the Potsdam consultation on meta-analysis. J Clin Epidemiol 48 (1995) 167-171
2. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., Stroup D.F., and for the QUORUM Group. Improving the quality of reports of meta-analyses of randomized controlled trials. Lancet 354 (1999) 1896-1900
3. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al., for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology. JAMA 283 (2000) 2008-2012
4. Nelson H.S., Weiss S.T., Bleecker E.R., Yancey S.W., and Dorinsky P.M. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129 (2006) 15-26
5. Nelson H.S. Is there a problem with inhaled long-acting β-adrenergic agonists?. J Allergy Clin Immunol 117 (2006) 3-16
6. Szefler S.J., Whelan G.J., and Leung D.Y.M. "Black box" warning: wake-up call or overreaction?. J Allergy Clin Immunol 117 (2006) 26-29
7. Pearlman D.S. Primum non nocere and "black box" warnings. J Allergy Clin Immunol 117 (2006) 30-31
8. Salpeter S.R., Buckley N.S., Ormiston T.M., and Salpeter E.E. Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 144 (2006) 904-912
9. Glassroth J. The role of long-acting β-agonists in the management of asthma: analysis, meta-analysis, and more analysis. Ann Intern Med 144 (2006) 936-937
10. Copas J., and Shi J.Q. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics 1 (2000) 247-262
11. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., and Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 295 (2006) 676-680
12. Holt S., Suder A., Weatherall M., Cheng S., Shirtcliffe E., and Beasley R. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 323 (2001) 1-8
13. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J.M., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
14. Jüni P., Witschi A., Bloch R., and Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282 (1999) 1054-1060
15. DerSimonium R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
16. Schmid J.E., Koch G.G., and LaVange L.M. An overview of statistical issues and methods of meta-analysis. J Biopharm Stat 1 (1991) 103-120